4.5 Article

Differential Associations of Chronic Inflammatory Diseases with Incident Heart Failure

Journal

JACC-HEART FAILURE
Volume 8, Issue 6, Pages 489-498

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jchf.2019.11.013

Keywords

autoimmune disorders; chronic inflammatory diseases; electronic cohort; heart failure; inflammation

Funding

  1. American Heart Association [16FTF31200010, 19TPA34890060]
  2. U.S. National Institutes of Health (NIH) [P30AI117943, UL1TR001422]
  3. NIH [KL2TR001424]
  4. Pfizer
  5. National Institutes of Health [R01 HL107577, R01 HL127028, R01 HL140731, R01 HL149423]
  6. Actelion
  7. AstraZeneca
  8. Corvia
  9. Novartis

Ask authors/readers for more resources

OBJECTIVES The purpose of this study was to compare the risks of incident heart failure (HF) among a variety of chronic inflammatory diseases (CIDs) and to determine whether risks varied by severity of inflammation within each CID. BACKGROUND Individuals with ODs are at elevated risk for cardiovascular diseases, but data are limited regarding risk for HF. METHODS An electronic health records database from a large urban medical system was examined, comparing individuals with ODs with frequency-matched controls without ODs, all of whom were receiving regular outpatient care. Rates of incident HF were determined by using the Kaplan-Meier method and subsequently used multivariate-adjusted proportional hazards models to compare HF risks for each CID. Exploratory analyses determined HF risks by proxy measurement of CID severity. RESULTS Of 37,636 patients (n = 18,278 patients with ODs; and n = 19,358 controls without CIDs) there were 960 incident HF cases over a median of 3.6 years. Risks for incident HF were significantly or borderline significantly elevated for patients with systemic sclerosis (hazard ratio [HR]: 7.26; 95% confidence interval [CI]: 5.72 to 9.21; p < 0.01), systemic lupus erythematosus (HR: 3.15; 95% CI: 2.41 to 4.11; p < 0.01), rheumatoid arthritis (HR: 1.39; 95% CI: 1.13 to 1.71; p < 0.01), and human immunodeficiency virus (HR: 1.28; 95% CI: 0.99 to 1.66; p = 0.06). There was no association between psoriasis or inflammatory bowel disease and incident HF, although patients with those CIDs with higher levels of C-reactive protein had higher risks for HF than controls. CONCLUSIONS Systemic sclerosis and systemic lupus erythematosus were associated with the highest risks of HF, followed by rheumatoid arthritis and HIV. Measurements of inflammation were associated with HF risk across different CIDs. (C) 2020 by the American College of Cardiology Foundation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available